July 22, 2021

Humana Inc. v. Regeneron Pharmaceuticals, Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 23, 2021

    Regeneron 'Kickbacks' Fueled Blockbuster Profits, Suit Says

    Insurance company Humana Inc. has accused Regeneron of inflating the cost of its vision loss drug Eylea by operating a purported scheme to make charitable donations to offset the price that patients pay for the drug.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS